XNCR Price / Book | Xencor, Inc

Xencor, Inc (XNCR) Price / Book

2026-09-03: Price/Book Ratio 3.93.
2026-06-30: Price/Book Ratio 2.38.
2026-03-31: Price/Book Ratio 1.73.
2025-12-31: Price/Book Ratio 1.73.

Historical market capitalization divided by filed shareholder equity.

Available history: 2013-12-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	3.93
2026-06-30	2.38
2026-03-31	1.73
2025-12-31	1.73
2025-09-30	1.34
2025-06-30	0.9
2025-03-31	1.18
2024-12-31	2.38
2024-09-30	1.94
2024-06-30	2.07
2024-03-31	2.23
2023-12-31	1.96
2023-09-30	1.83
2023-06-30	2.23
2023-03-31	2.46
2022-12-31	2.15
2022-09-30	2.15
2022-06-30	2.2
2022-03-31	2.08
2021-12-31	3.25
2021-09-30	3.08
2021-06-30	3.11
2021-03-31	4.3
2020-12-31	4.41
2020-09-30	3.91
2020-06-30	3.25
2020-03-31	2.87
2019-12-31	3.3
2019-09-30	3.13
2019-06-30	3.8
2019-03-31	2.87
2018-12-31	3.9
2018-09-30	4.12
2018-06-30	3.98
2018-03-31	3.1
2017-12-31	3.26
2017-09-30	3.7
2017-06-30	3.28
2017-03-31	3.68
2016-12-31	3.63
2016-09-30	4.98
2016-06-30	3.73
2016-03-31	3.44
2015-12-31	3.65
2015-09-30	3.23
2015-06-30	5.48
2015-03-31	3.65
2014-12-31	8.5
2014-09-30	4.89
2014-06-30	5.57
2014-03-31	5.25
2013-12-31	3.9

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Septerna, Inc. (SEPN)	United States	$1.783B	-63.01
ANI PHARMACEUTICALS INC (ANIP)	United States	$1.810B	18.77
COMPASS Pathways plc (CMPS)		$1.812B	-4.87
Eton Pharmaceuticals, Inc. (ETON)	United States	$1.701B	80.74
Zymeworks Inc. (ZYME)	United States	$1.902B	-12.44
Xeris Biopharma Holdings, Inc. (XERS)	United States	$1.632B	-80.10
Stoke Therapeutics, Inc. (STOK)	United States	$1.630B	-9.82
Rapport Therapeutics, Inc. (RAPP)	United States	$1.623B	-14.56
Sarepta Therapeutics, Inc. (SRPT)	United States	$1.941B	-13.89
Syndax Pharmaceuticals Inc (SNDX)	United States	$1.606B	-8.82